Literature DB >> 12424703

Immunopathogenesis of cerebral toxoplasmosis.

Yasuhiro Suzuki1.   

Abstract

Interferon (IFN)-gamma is an absolute requirement for resistance against acute acquired infection with Toxoplasma gondii and development of toxoplasmic encephalitis (TE) during the late stage of infection. Multiple populations of both T and non-T cells are important sources of IFN-gamma in resistance. In the absence of IFN-gamma-producing non-T cells, T cells cannot prevent TE. Interleukin-12, Bcl-3, NF-kappaB(2), and CD40-CD40L ligand interaction are important for up-regulation of IFN-gamma production. T. gondii infects a variety of host cells, and IFN-gamma-mediated immune responses control the parasite in both phagocytic and nonphagocytic cells through at least five different mechanisms, most likely depending on the types of cells responding to IFN-gamma. Such effector functions involve production of NO by iNOS, tryptophan degradation by the enzyme IDO (indolamine 2,3-dioxygenase), unidentified mechanism(s) mediated by 47- to 48-kDa proteins encoded by an IFN-gamma responsive gene family, limiting the availability of intracellular iron to the parasite, and production of reactive oxygen intermediates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12424703     DOI: 10.1086/344276

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  Strains of Toxoplasma gondii used for tachyzoite antigens to stimulate spleen cells of infected mice in vitro affect cytokine responses of the cells in the culture.

Authors:  Laurel Rodgers; Xisheng Wang; Xiangshu Wen; Bradley Dunford; Renee Miller; Yasuhiro Suzuki
Journal:  Parasitol Res       Date:  2005-07-07       Impact factor: 2.289

Review 2.  Advances in imaging the innate and adaptive immune response to Toxoplasma gondii.

Authors:  Beena John; Wolfgang Weninger; Christopher A Hunter
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

3.  Cytokine and antibody responses of reactivated murine toxoplasmosis upon administration of dexamathasone.

Authors:  Ki-Nam Kang; In-Uk Choi; Dae-Whan Shin; Young-Ha Lee
Journal:  Korean J Parasitol       Date:  2006-09       Impact factor: 1.341

4.  Comparison of dynamic expressions of Tim-3 and PD-1 in the brains between toxoplasmic encephalitis-resistant BALB/c and -susceptible C57BL/6 mice.

Authors:  Bin Wu; Xiaoyin Fu; Bo Huang; Xinxin Tong; Huanqin Zheng; Shiguang Huang; Fangli Lu
Journal:  Parasitol Res       Date:  2014-01-31       Impact factor: 2.289

5.  Toxoplasmosis.

Authors:  Sandra K Halonen; Louis M Weiss
Journal:  Handb Clin Neurol       Date:  2013

6.  Infection of immunodeficient horses with Sarcocystis neurona does not result in neurologic disease.

Authors:  Debra C Sellon; Donald P Knowles; Ellis C Greiner; Maureen T Long; Melissa T Hines; Tressa Hochstatter; Ahmed Tibary; John B Dame
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

7.  Molecular diagnosis of toxoplasmosis in immunocompromised patients: a 3-year multicenter retrospective study.

Authors:  Florence Robert-Gangneux; Yvon Sterkers; Hélène Yera; Isabelle Accoceberry; Jean Menotti; Sophie Cassaing; Marie-Pierre Brenier-Pinchart; Christophe Hennequin; Laurence Delhaes; Julie Bonhomme; Isabelle Villena; Emeline Scherer; Frédéric Dalle; Feriel Touafek; Denis Filisetti; Emmanuelle Varlet-Marie; Hervé Pelloux; Patrick Bastien
Journal:  J Clin Microbiol       Date:  2015-03-11       Impact factor: 5.948

8.  Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly.

Authors:  Adriana Lima Vallochi; Anna Carla Goldberg; Angela Falcai; Rajendranath Ramasawmy; Jorge Kalil; Cláudio Silveira; Rubens Belfort; Luiz Vicente Rizzo
Journal:  Clin Ophthalmol       Date:  2008-12

9.  CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis.

Authors:  Mahmoud Nateghi Rostami; Hossein Keshavarz; Rosita Edalat; Abdolfattah Sarrafnejad; Tahereh Shahrestani; Fereidoun Mahboudi; Ali Khamesipour
Journal:  PLoS Negl Trop Dis       Date:  2010-10-12

10.  Therapeutic administration of KM+ lectin protects mice against Paracoccidioides brasiliensis infection via interleukin-12 production in a toll-like receptor 2-dependent mechanism.

Authors:  Kely C Coltri; Leandro L Oliveira; Camila F Pinzan; Patrícia E Vendruscolo; Roberto Martinez; Maria Helena Goldman; Ademilson Panunto-Castelo; Maria-Cristina Roque-Barreira
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.